Improving melanoma classification by integrating genetic and morphologic features

Amaya Viros ¹, Jane Fridlyand , Juergen Bauer

⁰Department of Dermatology, University of California San Francisco, San Francisco, California, United States of America.

Plos Medicine +

|

June 6, 2008

View abstract on PubMed

Summary

Histomorphologic features can predict BRAF mutations in melanoma, aiding therapy stratification. Younger age (<55) is a key predictor, linked to distinct metastasis patterns and survival benefits.

Area Of Science

Oncology
Dermatology
Genetics

Background

Melanoma classification traditionally relies on morphology, but lacks predictive power for metastatic disease treatment.
Genetic alterations, particularly BRAF and NRAS mutations, are key drivers of melanoma and therapeutic targets.
Identifying morphological surrogates for genetic alterations can improve patient stratification and clinical trial analysis.

Purpose Of The Study

To define and assess histomorphologic measures for predicting BRAF and NRAS mutations in primary cutaneous melanomas.
To evaluate the clinical utility of morphological features and age as surrogates for BRAF mutation status.
To correlate BRAF mutation status with patient survival and metastatic patterns.

Main Methods

A panel of histomorphologic measures was assessed in 302 archival primary cutaneous melanoma tissues.
Morphological features were correlated with BRAF and NRAS oncogene mutation status.
Age (<55 years) was evaluated as a surrogate for BRAF mutation in an independent cohort of 4,785 patients.

Main Results

Melanomas with BRAF mutations exhibited distinct features: increased intraepidermal melanocyte migration, epidermal thickening, sharper demarcation, and larger, rounder, pigmented tumor cells (p<0.0001).
BRAF mutation status was predictable with up to 90.8% accuracy using morphological features and age <55.
Age <55 was the most predictive factor for BRAF mutation, associated with improved survival and a distinct pattern of lymph node metastasis.

Conclusions

Refined morphological classification of primary melanomas can create genetically homogeneous subgroups.
These subgroups are likely to exhibit differences in clinical outcomes and metastatic patterns.
This approach can enhance melanoma classification, facilitate therapy stratification, and aid retrospective analysis of clinical trial data.

Related Concept Videos